| Literature DB >> 32605282 |
Alan R Lear1, Jonah Lenters1, Michael G Patterson2, Richard J Staples3, Eric J Werner2, Shannon M Biros1.
Abstract
This paper describes the synthesis of two beta-phosphorylamide ligands and their coordination chemistry with the Ln ions Tb3+, Eu3+, and Sm3+. Both the ligands and Ln complexes were characterized by IR, NMR, MS, and X-ray crystallography. The luminescence properties of the Tb3+ and Eu3+ complexes were also characterized, including the acquisition of lifetime decay curves. In the solid state, the Tb3+ and Sm3+ ligand complexes were found to have a 2:2 stoichiometry when analyzed by X-ray diffraction. In these structures, the Ln ion was bound by both oxygen atoms of each beta-phosphorylamide moiety of the ligands. The Tb3+ and Eu3+ complexes were modestly emissive as solutions in acetonitrile, with lifetime values that fell within typical ranges.Entities:
Keywords: X-ray crystallography; carbamoylmethylphosphine oxide (CMPO); lanthanide coordination chemistry; lanthanide luminescence
Year: 2020 PMID: 32605282 PMCID: PMC7411983 DOI: 10.3390/molecules25132971
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Synthetic pathways to (a) ligands 1 and 2, along with (b) their 2:2 Ln ligand complexes. The Ln ligand complex shown in part (b) has been simplified for clarity; details regarding the precise coordination environments, including metal-bound nitrate groups and solvent molecules, are described with the X-ray diffraction studies.
FT-IR data of ligands 1 and the resultant Ln complexes; peak values reported in wavenumbers (cm−1).
| Stretch | Ligand 1 | Sm-1 | Eu-1 | Tb-1 | Ligand 2 | Sm-2 | Eu-2 | Tb-2 |
|---|---|---|---|---|---|---|---|---|
| C=O | 1666 | 1626 | 1627 | 1627 | 1661 | 1623 | 1621 | 1621 |
| P=O | 1203 | 1191 | 1191 | 1191 | 1173 | 1157 | 1156 | 1156 |
| P-O | 1016 | 1014 | 1013 | 1014 | ----- | ----- | ----- | ----- |
| N-H | 3268 | 3317 | 3328 | 3321 | 3271 | weak | weak | weak |
Figure 2X-ray crystal structures of organic ligands 1 [25] and 2. Thermal ellipsoids are depicted at the 50% probability level using standard CPK colors, and all hydrogen atoms bonded to carbon atoms have been omitted for clarity. Only the major component of compound 2 is shown here; details regarding the treatment of this disorder are given in the Supplementary Materials.
Crystal data and structure refinement for free ligand 2, and the metal complexes [Sm(NO3)3(1)]2•(CH3CN), [Tb(NO3)3(1)]2•(CH3CN), [Sm(NO3)3(2)]2•H2O, and [Tb(NO3)3(2)(H2O)2]2, [Tb(NO3)3(2)(MeOH)]2.
| Structure Number | 2 | [Sm(NO3)3(1)]2• (CH3CN) | [Tb(NO3)3(1)]2•(CH3CN) | [Sm(NO3)3(2)]2•H2O | [Tb(NO3)3(2)(H2O)2]2 | [Tb(NO3)3(2)(MeOH)]2 |
|---|---|---|---|---|---|---|
| CCDC number | 2003372 | 2003370 | 2003373 | 2003369 | 2003374 | 2003371 |
| Empirical formula | C30H30N2O4P2 | C32H66N12O34P4Sm2 | C32H66N12O34P4Tb2 | C60H64N10O28P4Sm2 | C60H72N10O32P4Tb2 | C64H76N10O30P4Tb2 |
| Formula weight | 544.50 | 1587.54 | 1604.68 | 1797.79 | 1886.99 | 1907.06 |
| Temperature/K | 173(2) | 173(2) | 173(2) | 173(2) | 173(2) | 173(2) |
| Crystal system | monoclinic | monoclinic | monoclinic | monoclinic | triclinic | tetragonal |
| Space group | P21/c | C2/c | C2/c | P21/n | P-1 | P-421c |
| a/Å | 5.65550(10) | 32.318(11) | 32.3189(5) | 10.5235(15) | 11.438(2) | 18.2898(4) |
| b/Å | 28.8994(5) | 12.538(4) | 12.5255(2) | 18.133(3) | 12.724(2) | 18.2898(4) |
| c/Å | 8.4517(2) | 16.447(6) | 16.4158(3) | 19.488(3) | 14.681(3) | 27.4073(6) |
| α/° | 90 | 90 | 90 | 90 | 91.784(2) | 90 |
| β/° | 109.4290(10) | 116.217(4) | 116.1620(10) | 96.944(12) | 106.593(2) | 90 |
| γ/° | 90 | 90 | 90 | 90 | 113.139(2) | 90 |
| Volume/Å3 | 1302.69(5) | 5979(4) | 5964.48(18) | 3691.6(9) | 1857.8(6) | 9168.2(4) |
| Z | 2 | 4 | 4 | 2 | 1 | 4 |
| ρcalcg/cm3 | 1.388 | 1.764 | 1.787 | 1.617 | 1.687 | 1.382 |
| μ/mm−1 | 1.848 | 2.154 | 13.430 | 13.393 | 2.068 | 8.794 |
| F(000) | 572.0 | 3192.0 | 3216.0 | 1804.0 | 948.0 | 3840.0 |
| Crystal size/mm3 | 0.169 × 0.093 × 0.035 | 0.279 × 0.218 × 0.082 | 0.264 × 0.173 × 0.103 | 0.262 × 0.126 × 0.063 | 0.187 × 0.11 × 0.038 | 0.284 × 0.2 × 0.183 |
| Radiation | CuKα (λ = 1.54178) | MoKα (λ = 0.71073) | CuKα (λ = 1.54178) | CuKα (λ = 1.54178) | MoKα (λ = 0.71073) | CuKα (λ = 1.54178) |
| 2Θ range for data collection/° | 6.116 to 136.61 | 3.54 to 52.802 | 6.094 to 140.374 | 6.68 to 143.44 | 3.528 to 50.95 | 5.81 to 136.676 |
| Index ranges | −6 ≤ h ≤ 6, −34 ≤ k ≤ 34, −10 ≤ l ≤ 10 | −40 ≤ h ≤ 40, −15 ≤ k ≤ 15, −20 ≤ l ≤ 20 | −39 ≤ h ≤ 39, −15 ≤ k ≤ 15, −17 ≤ l ≤ 19 | −12 ≤ h ≤ 12, −22 ≤ k ≤ 22, −23 ≤ l ≤ 21 | −13 ≤ h ≤ 13, −12 ≤ k ≤ 15, −17 ≤ l ≤ 16 | −22 ≤ h ≤ 22, −21 ≤ k ≤ 22, −33 ≤ l ≤ 33 |
| Reflections collected | 17,978 | 26,038 | 44,653 | 24,709 | 18,678 | 111,590 |
| Independent reflections | 2388 [Rint = 0.0757, Rsigma = 0.0373] | 6120 [Rint = 0.0770, Rsigma = 0.0704] | 5582 [Rint = 0.0588, Rsigma = 0.0348] | 6996 [Rint = 0.1460, Rsigma = 0.1397] | 6825 [Rint = 0.0585, Rsigma = 0.0735] | 8408 [Rint = 0.1335, Rsigma = 0.0634] |
| Data/restraints/parameters | 2388/0/213 | 6120/1/402 | 5582/0/402 | 6996/48/472 | 6825/0/492 | 8408/165/536 |
| Goodness-of-fit on F2 | 1.022 | 1.058 | 1.086 | 1.020 | 1.024 | 1.094 |
| Final R indexes [I> = 2σ (I)] | R1 = 0.0468, wR2 = 0.1144 | R1 = 0.0532, wR2 = 0.1296 | R1 = 0.0287, wR2 = 0.0636 | R1 = 0.0722, wR2 = 0.1524 | R1 = 0.0626, wR2 = 0.1578 | R1 = 0.0638, wR2 = 0.1895 |
| Final R indexes [all data] | R1 = 0.0610, wR2 = 0.1234 | R1 = 0.0776, wR2 = 0.1487 | R1 = 0.0336, wR2 = 0.0653 | R1 = 0.1453, wR2 = 0.1815 | R1 = 0.0791, wR2 = 0.1717 | R1 = 0.0827, wR2 = 0.2052 |
| Largest diff. peak/hole/e Å−3 | 0.67/−0.34 | 3.54/−0.79 | 0.57/−0.75 | 0.91/−0.91 | 3.52/−1.60 | 1.10/−0.77 |
| 0.023(4) |
Selected bond distances (Å) and angles (°) for ligand 1[25] and its Sm(NO3)3 (dimeric), Sm(NO3)3 (polymeric) [26], and Tb(NO3)3 complexes.
| Ligand 1 [ | [Sm(NO3)3(1)]2• (CH3CN) | [Sm(NO3)3(1)]2(polymer) [ | [Tb(NO3)3(1)]2• (CH3CN) | |
|---|---|---|---|---|
| ligand | ||||
| C=O | 1.226(2) | 1.242(7), 1.242(7) | 1.245(5), 1.249(4) | 1.246(4), 1.245(4) |
| P=O | 1.474(2) | 1.473(4), 1.478(4) | 1.482(3), 1.485(3) | 1.477(2), 1.478(3) |
| P-O | 1.5791(16), 1.5619(15) | 1.551(5), 1.552(5), 1.551(5), 1.563(5) | 1.515(4), 1.537(4), 1.553(3), 1.542(3) | 1.554(2), 1.560(3), 1.564(3), 1.561(3) |
| Ln-O(C) | ----- | 2.387(4), 2.417(4) | 2.387(3), 2.382(3) | 2.378(2), 2.400(2) |
| Ln-O(P) | ----- | 2.400(4), 2.434(4) | 2.344(3), 2.340(3) | 2.390(2), 2.424(2) |
| C(O)-C-P(O) | 110.9(2) | 110.6(4), 113.1(4) | 109.7(3), 110.1(3) | 110.4(2), 111.2(2) |
| O(C)-Ln-O(P) | ----- | 75.24(14), 73.53(15) | 74.17(10), 74.70(9) | 75.44(8), 74.06(8) |
| inner sphere water | ||||
| Ln-O(water) | ----- | ----- | 2.413(3) | ----- |
Selected bond distances (Å) and angles (°) for ligand 2 and its Sm(NO3)3 and Tb(NO3)3 complexes. For the Tb(NO3)3 complex, only the atoms that were not disordered are included here.
| Ligand 2 | [Sm(NO3)3(2)]2•H2O | [Tb(NO3)3(2)(MeOH)]2 | [Tb(NO3)3(2)(H2O)2]2 | |
|---|---|---|---|---|
| ligand | ||||
| C=O | 1.224(3) | 1.251(11), 1.253(13) | 1.245(15), 1.255(14) | 1.262(8), 1.266(9) |
| P=O | 1.4912(18) | 1.511(7), 1.508(7) | 1.505(9) | 1.511(5), 1.509(5) |
| Ln-O(C) | ----- | 2.514(7), 2.396(7) | 2.365(8), 2.372(8) | 2.412(5), 2.352(5) |
| Ln-O(P) | ----- | 2.360(7), 2.387(7) | 2.332(8) | 2.277(5), 2.310(5) |
| C(O)-C-P(O) | 111.80(17) | 113.0(7), 115.0(8) | 111.7(9) | 112.8(5), 111.3(5) |
| O(C)-Ln-O(P) | ----- | 76.1(2), 74.5(2) | 75.3(3) | 79.05(17), 77.64(18) |
| inner sphere water | ||||
| Ln-O(water) | ----- | ----- | ----- | 2.356(5), 2.414(6) |
Figure 3X-ray crystal structure of the [Sm(NO3)3(1)](CH3CN) complex, using standard CPK colors for the atoms of ligand 1 (Sm3+ = purple spheres). The atoms of the nitrate groups and solvent acetonitrile are depicted as grey spheres to make it easier to visualize the structure of the ligands and the metal’s coordination geometry. Thermal ellipsoids are drawn at the 40% probability level, only hydrogen atoms bonded to nitrogen atoms are shown for clarity, and the hydrogen bonding interaction is depicted with a purple, dashed line. Only the major component is shown for clarity. The Tb3+ complex is isomorphic to this structure, and shown in the Supplementary Materials.
Figure 4X-ray crystal structures of the 2:2 complexes between phenyl-substituted ligand 2 and Sm(NO3)3 and Tb(NO3)3 using standard CPK colors (Sm3+: purple, Tb3+: green). The atoms of the nitrate groups are colored grey in order to make it easier to visualize the ligand and metal coordination geometry. Thermal ellipsoids are drawn at the 40% probability level, and hydrogen bonding interactions are depicted with purple, dashed lines. (a) The [Sm(NO3)3(2)(H2O)2]2 complex; (b) the 2:2 [Tb(NO3)3(2)]2•H2O complex; (c) the major component of the 2:2 [Tb(NO3)3(2)(MeOH)]2 complex. For clarity, only the ipso carbon atom of each phenyl ring is shown, and only the hydrogen atoms bonded to oxygen or nitrogen atoms are shown. Complete structures are shown in the Supplementary Materials.
Figure 51H NMR spectra of ligands 1 and 2, along with their Sm(NO3)3 complexes. (Top): ligand 1 in CDCl3, and with 1 eq. Sm(NO3)3 in CD3CN. (Bottom): ligand 2 in CDCl3, and with 1 eq. Sm(NO3)3 in CD3CN. For all spectra, the key resonances have been labeled as: -NH (green square), -P-CH2-C- (red circle), -NH-CH2- (blue star).
Figure 6Absorption (solid line) and excitation (dashed line) spectra for the (left) Eu(NO3)3(1) and (right) Eu(NO3)3(2) complexes in acetonitrile (1.0 mM complex concentration, emission wavelengths were monitored at 620 nm for the complex with ligand 1, and 617 nm for the complex with ligand 2, 2.0 nm excitation and emission slit widths). Note that the intensity values of all the spectra shown here have been normalized to have their λmax equal one (1.0) for ease of comparison.
Figure 7Emission spectra of the solutions of ligands 1 (left) and 2 (right), with one equivalent of Eu(NO3)3 and Tb(NO3)3 in acetonitrile. For ligand 1: excitation wavelength 238 nm, excitation and emission slit widths = 5 nm, 2.2 mM ligand concentration; for ligand 2: excitation wavelength 260 nm, excitation and emission slit widths = 2 nm, 1.0 mM ligand concentration. Note: for the acquisition of the emission spectra of the ligand 1 complexes, the complex concentration is more than twice that of ligand 2, and the excitation and emission slits were widened to accommodate the dimmer emission of these complexes.
Emission lifetimes for 1:1 complexes of Eu(NO3)3 and Tb(NO3)3 with ligand 2 in acetonitrile. The error bars on these numbers represent the standard deviation from three trials.
| Ligand 2 Complex | τACN/ms |
|---|---|
| Eu | 1.35 ± 0.08 (at 616 nm) |
| Tb | 1.83 ± 0.05 (at 545 nm) |